Ranitidine Market, By Strength (75 mg, 150 mg, and 300 mg), By Indication (Intestinal& Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, and Others), By Dosage Form (Tablets, Syrups, and Injections), By Route of Administration (Oral and Injectable), By Distribution Channel (Hospital pharmacies, Retail Pharmacies, and Online Pharmacies) and Region - Trends, Analysis and Forecast till 2030

Introduction:

Ranitidine is a drug which belongs to drug class called histamine-2 blockers, which work by reducing the amount of acid produced in stomach. Ranitidine is mainly used in treatment of intestinal & stomach ulcers, gastroesophageal reflux disease (gerd), esophagitis, and zollinger-ellison syndrome. Ranitidine is a drug of class histamine-2 blockers which reduces amount of acid produced in stomach. The ranitidine is widely applicable in treatment of certain stomach and throat (esophagus) related problems such as intestinal & stomach ulcers, gastroesophageal reflux disease (gerd), esophagitis, and zollinger-ellison syndrome. Currently, ranitidine is available in three strengths 75 mg, 150 mg, and 300 mg. It can be taken orally or can be administrated by injections. Ranitidine was developed in 1976 and came into commercial use in 1981, it is one of the essential medicine in World Health Organization's List of essential medicines Ranitidine Market accounted for US$ 441.24 million in 2020 and is estimated to be US$ 562.09 million by 2030 and is anticipated to register a CAGR of 2.5%.

Owing to launch of Ranitidine

The ranitidine is expected to show a significant growth over the forecast period owing to launch of ranitidine in key markets by big players. For instance, in February 2018, Strides Pharma Science Limited launched its ranitidine tablets USP, 150 mg, indicated for treatment of peptic ulcers of stomach and intestines, in the U.S. market.

High prevalence of stomach and throat related disorder

High prevalence of stomach and throat (esophagus) related disorder is also expected to significantly raise demand for ranitidine and drive its market growth over the forecast period of time. For instance, according to the Centers of Disease Control and Prevention Estimations in U.S. over 25Mn Americans will suffer from an ulcer at some point during their lifetime. Furthermore, key players in the market are working to gain approval for its new ranitidine products by major regulatory of key regions, approval of new products in key regions is also expected to cater the market growth over the forecast period of time. For instance, in August 2018, Granules India Limited received U.S. Food & Drug Administration (US FDA) approval for its Abbreviated New Drug Application (ANDA) filed by company for ranitidine tablets USP, 150 mg, and 150 mg Cool Mint (OTC). In 2011, Perrigo Company received the U.S. Food and Drug Administration approval for its abbreviated new drug application for over-the-counter (OTC) ranitidine 150 (regular and cool mint), a generic version of Zantac 150 and launched it globally in 2012.

The ranitidine market has been segmented on the basis of strength, indication, dosage form, route of administration, distribution channel, and region.

On the basis of strength, the ranitidine market has been segmented in 75 mg, 150 mg, and 300 mg. On the basis of indication, the ranitidine market has been segmented in intestinal & stomach ulcers, gastroesophageal reflux disease (GERD), esophagitis, zollinger-ellison syndrome, and others. On the basis of dosage form, the ranitidine market has been segmented in tablets, syrups, and injections. On the basis of route of administration, the ranitidine market has been segmented in oral and injectable. On the basis of distribution channel, the ranitidine market has been segmented in hospital pharmacies, retail pharmacies, and online pharmacies.

Regional Insights:

For detailed understanding of market dynamics, on the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions. For detailed understanding of market dynamics, the ranitidine market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Attribute	Details
Base year for estimation	2020
Forecast period	2020 – 2030
Market representation	Revenue in USD Million & CAGR from 2020 – 2030
Market Segmentation	By Strength- 75 mg, 150 mg, and 300 mg By Indication- Intestinal & Stomach Ulcers, Gastroesophageal Reflux Disease (GERD), Esophagitis, Zollinger-Ellison Syndrome, And Others By Dosage Form- Tablets, Syrups, And Injections By Route of Administration- Oral And Injectable By Distribution Channel- Hospital Pharmacies, Retail Pharmacies, And Online Pharmacies
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Detailed Segmentation:

Ranitidine Market, By Strength:

• 75 mg
  • 300 mg
  • 150 mg

Ranitidine Market, By Indication:

• Intestinal & Stomach Ulcers
  • Others
  • Zollinger-Ellison Syndrome
  • Esophagitis
  • Gastroesophageal Reflux Disease (GERD)

Ranitidine Market, By Dosage Form:

• Tablets
  • Injections
  • Syrups

Ranitidine Market, By Route of Administration

• Oral
  • Injectable

Ranitidine Market, By Distribution Channel:

• Retail Pharmacy
  • Hospitals
  • Online Pharmacy

Ranitidine Market, By Region:

• North America
  • North America Ranitidine Market, By Strength
  • North America Ranitidine Market, By Indication
  • North America Ranitidine Market, By Dosage Form
  • North America Ranitidine Market, By Route of Administration
  • North America Ranitidine Market, By Distribution Channel
  • North America Ranitidine Market, By Country
    • U.S.
    • Canada

• • • Europe
      • Europe Ranitidine Market, By Strength
      • Europe Ranitidine Market, By Indication
      • Europe Ranitidine Market, By Dosage Form
      • Europe Ranitidine Market, By Route of Administration
      • Europe Ranitidine Market, By Distribution Channel
      • Europe Ranitidine Market, By Country
        • Germany
        • UK
        • France
        • Russia
        • Italy
        • Switzerland
        • Sweden
        • Rest of Europe

• Asia-Pacific
  • Asia-Pacific Ranitidine Market, By Strength
  • Asia Pacific Ranitidine Market, By Indication
  • Asia Pacific Ranitidine Market, By Dosage Form
  • Asia Pacific Ranitidine Market, By Route of Administration
  • Asia-Pacific Ranitidine Market, By Distribution Channel
  • Asia-Pacific Ranitidine Market, By Country
    • China
    • India
    • Australia & New Zealand
    • Japan
    • South Korea
    • Rest of Asia Pacific

• Latin America
  • Latin AmericaRanitidine Market, By Strength
  • Latin America Ranitidine Market, By Indication
  • Latin America Ranitidine Market, By Dosage Form
  • Latin America Ranitidine Market, By Route of Administration
  • Latin America Ranitidine Market, By Distribution Channel
  • Latin AmericaRanitidine Market, By Country
    • Brazil
    • Mexico
    • Argentina and Chile
    • Rest of Latin America

• Middle East
  • Middle East Ranitidine Market, By Strength
  • Middle East Ranitidine Market, By Indication
  • Middle East Ranitidine Market, By Dosage Form
  • Middle East Ranitidine Market, By Route of Administration
  • Middle East Ranitidine Market, By Distribution Channel
  • Middle East Ranitidine Market, By Country
    • GCC
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East

• Africa
  • Africa Ranitidine Market, By Strength
  • Africa Ranitidine Market, By Indication
  • Africa Ranitidine Market, By Dosage Form
  • Africa Ranitidine Market, By Route of Administration
  • Africa Ranitidine Market, By Distribution Channel
  • Africa Ranitidine Market, By Country
    • North Africa
    • Central Africa
    • South Africa

Key players operating in the ranitidine market includes, Sun Pharmaceutical Industries Limited,Granules India Limited, GlaxoSmithKline plc, BoehringerIngelheim GmbH, Strides Pharma Science Limited (StridesShasun), Tocris Bioscience (R & D Systems), Merck KGaA, and others. For instance, , in February 2018, Strides Pharma Science Limited launched its ranitidine tablets USP, 150 mg, indicated for treatment of peptic ulcers of stomach and intestines, in the U.S. market.

o    Sun Pharmaceutical Industries Limited

• Company Overview
  • Merck KGaA
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • Tocris Bioscience (R & D Systems)
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • Strides Pharma Science Limited (StridesShasun)
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • BoehringerIngelheim GmbH
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • GlaxoSmithKline plc
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • Granules India Limited
    • • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Business Strategies Overview
  • Business Strategies Overview
  • Financial Performance
  • Key Highlights
  • Product Portfolio

1. Research Objective and Assumption
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Preview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snippet, By Strength
     • Market Snippet, By Indication
     • Market Snippet, By Dosage Form
     • Market Snippet, By Route of Administration
     • Market Snippet, By Distribution Channel
     • Market Snippet, By Region
   • Opportunity Map Analysis
3. Market Dynamics Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
     • Drivers- Restraints Impact Analysis
     • PEST Analysis
     • Porter’s Five Forces Analysis
4. Market Segmentation, By Strength, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
   • Segment Trends 75 mg
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • 150 mg
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • 300 mg
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
5. Market Segmentation, By Indication, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Segment Trends
   • Intestinal & Stomach Ulcers
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Gastroesophageal Reflux Disease (GERD
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Esophagitis
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Zollinger-Ellison Syndrome
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Others
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
6. Market Segmentation, Dosage Form, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Segment Trends
   • Tablets
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Syrups
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Injections
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
7. Market Segmentation, Route of Administration, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Segment Trends
   • Oral
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
   • Injectable
     • Introduction
     • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028

8.      Market Segmentation, By Distribution Channel, 2018 – 2028, (US$ Mn)

1. Introduction
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
   • Y-o-Y Growth Analysis (%), 2019 – 2028
   • Segment Trends
2. Retail Pharmacies
   • Introduction
   • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
3. Online Pharmacies
   • Introduction
   • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
4. Hospitals Pharmacies
   • Introduction
   • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
5. Global Market, By Region, 2018 – 2028, (US$ Mn)
   • Introduction
     • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
     • Y-o-Y Growth Analysis (%), 2019 – 2028
     • Regional Trends
   • North America
     • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
     • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
     • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
     • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  U.S.

Ø  Canada

1. Latin America
   • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile   

Ø  Rest of Latin America

Ø  Europe

1. Europe
   • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe           

1. Asia Pacific
   • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

1. Middle East
   • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

1. Africa
   • Market Size and Forecast (US$ Mn), By Strength, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Indication, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
   • Market Size and Forecast (US$ Mn), By Country, 2018 – 2028

Ø  South Africa

Ø  Central Africa

Ø  North Africa

1. Competitive Landscape
   • Heat Map Analysis
   • Company Profiles
     • Sun Pharmaceutical Industries Limited

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1.  
   • Granules India Limited

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1.  
   • GlaxoSmithKline plc

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

§  BoehringerIngelheim GmbH

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1.  
   • Strides Pharma Science Limited (StridesShasun)

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1.  
   • Tocris Bioscience (R & D Systems)

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1.  
   • Merck KGaA

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

1. Analyst Views
2. Section
   • Research Methodology
   • About Us
   • Contact